Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kriaa

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Transplant Immunology|May 12, 2007
Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockadeH Chavez, S Beaudreuil, K Abbed, et al.
Transplantation Proceedings|March 26, 2004
Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patientsR Snanoudj, F Kriaa, N Arzouk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 12, 2006
Long-term results (10 years) of a prospective trial comparing Lo-tact-1 monoclonal antibody and anti-thymocyte globulin induction therapy in kidney transplantationS Beaudreuil, A Durrbach, J Noury, et al.
Kidney International. Supplement|October 1, 1992
How to deal with the hyperimmunized potential recipientsB M Charpentier, C Hiesse, F Kriaa, et al.
Clinical Transplantation|March 19, 1999
Human parvovirus B19 infection in organ transplant recipientsS Marchand, G Tchernia, C Hiesse, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Prophylactic use of the IL-2 receptor-specific monoclonal antibody LO-Tact-1 with cyclosporin A and steroids in renal transplantationC Hiesse, F Kriaa, P Alard, et al.
Annales De Medecine Interne|January 1, 1992
Anti-HLA antibodies depletion on protein A-sepharose columns in hyperimmunized patients awaiting renal transplantationF Kriaa, P Rousseau, C Hiesse, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 22, 2000
[Which urologic treatment alternatives are there for the hemophiliac patient?]G Benoit, T Lambert, P Blanchet, et al.
British Journal of Haematology|September 21, 2001
Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophiliaB Guillet, F Kriaa, M G Huysse, et al.
The New England Journal of Medicine|January 6, 1994
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndromeJ Dantal, E Bigot, W Bogers, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Transplant Immunology|May 12, 2007
Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockadeH Chavez, S Beaudreuil, K Abbed, et al.
Transplantation Proceedings|March 26, 2004
Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patientsR Snanoudj, F Kriaa, N Arzouk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 12, 2006
Long-term results (10 years) of a prospective trial comparing Lo-tact-1 monoclonal antibody and anti-thymocyte globulin induction therapy in kidney transplantationS Beaudreuil, A Durrbach, J Noury, et al.
Kidney International. Supplement|October 1, 1992
How to deal with the hyperimmunized potential recipientsB M Charpentier, C Hiesse, F Kriaa, et al.
Clinical Transplantation|March 19, 1999
Human parvovirus B19 infection in organ transplant recipientsS Marchand, G Tchernia, C Hiesse, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Prophylactic use of the IL-2 receptor-specific monoclonal antibody LO-Tact-1 with cyclosporin A and steroids in renal transplantationC Hiesse, F Kriaa, P Alard, et al.
Annales De Medecine Interne|January 1, 1992
Anti-HLA antibodies depletion on protein A-sepharose columns in hyperimmunized patients awaiting renal transplantationF Kriaa, P Rousseau, C Hiesse, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 22, 2000
[Which urologic treatment alternatives are there for the hemophiliac patient?]G Benoit, T Lambert, P Blanchet, et al.
British Journal of Haematology|September 21, 2001
Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophiliaB Guillet, F Kriaa, M G Huysse, et al.
The New England Journal of Medicine|January 6, 1994
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndromeJ Dantal, E Bigot, W Bogers, et al.
Pageof 2